SNSE
Price
$0.35
Change
-$0.00 (-0.00%)
Updated
Jun 5, 04:59 PM (EDT)
Capitalization
9.1M
56 days until earnings call
ZLDAF
Price
$0.28
Change
+$0.06 (+27.27%)
Updated
Jun 4 closing price
Capitalization
3.46M
Interact to see
Advertisement

SNSE vs ZLDAF

Header iconSNSE vs ZLDAF Comparison
Open Charts SNSE vs ZLDAFBanner chart's image
Sensei Biotherapeutics
Price$0.35
Change-$0.00 (-0.00%)
VolumeN/A
Capitalization9.1M
Zelira Therapeutics
Price$0.28
Change+$0.06 (+27.27%)
Volume$1K
Capitalization3.46M
SNSE vs ZLDAF Comparison Chart
Loading...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SNSE vs. ZLDAF commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SNSE is a Hold and ZLDAF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (SNSE: $0.35 vs. ZLDAF: $0.28)
Brand notoriety: SNSE and ZLDAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SNSE: 55% vs. ZLDAF: 772%
Market capitalization -- SNSE: $8.88M vs. ZLDAF: $3.32M
SNSE [@Biotechnology] is valued at $8.88M. ZLDAF’s [@Biotechnology] market capitalization is $3.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SNSE’s FA Score shows that 1 FA rating(s) are green whileZLDAF’s FA Score has 0 green FA rating(s).

  • SNSE’s FA Score: 1 green, 4 red.
  • ZLDAF’s FA Score: 0 green, 5 red.
According to our system of comparison, both SNSE and ZLDAF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SNSE’s TA Score shows that 4 TA indicator(s) are bullish.

  • SNSE’s TA Score: 4 bullish, 4 bearish.

Price Growth

SNSE (@Biotechnology) experienced а +19.36% price change this week, while ZLDAF (@Biotechnology) price change was +26.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

SNSE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNSE($9.1M) has a higher market cap than ZLDAF($3.46M). ZLDAF (-27.102) and SNSE (-28.158) have similar YTD gains . ZLDAF has higher annual earnings (EBITDA): -3.17M vs. SNSE (-28.38M). ZLDAF has higher revenues than SNSE: ZLDAF (40.9K) vs SNSE (0).
SNSEZLDAFSNSE / ZLDAF
Capitalization9.1M3.46M263%
EBITDA-28.38M-3.17M895%
Gain YTD-28.158-27.102104%
P/E RatioN/AN/A-
Revenue040.9K-
Total Cash47MN/A-
Total Debt4.47MN/A-
FUNDAMENTALS RATINGS
ZLDAF: Fundamental Ratings
ZLDAF
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SNSE
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HACAX116.99N/A
N/A
Harbor Capital Appreciation Instl
FTVFX32.96N/A
N/A
Fidelity Advisor Value M
BSMKX16.34N/A
N/A
iShares Russell Small/Mid-Cap Idx K
HLSCX22.80N/A
N/A
Hartford Disciplined Equity HLS IC
BCIIX18.09N/A
N/A
Brown Capital Mgmt Intl All Com Inv

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+4.14%
VSTM - SNSE
47%
Loosely correlated
+4.58%
ALZN - SNSE
40%
Loosely correlated
+3.66%
GRI - SNSE
39%
Loosely correlated
+7.41%
INAB - SNSE
38%
Loosely correlated
-0.97%
FATE - SNSE
36%
Loosely correlated
+4.41%
More

ZLDAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDAF has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDAF jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDAF
1D Price
Change %
ZLDAF100%
+26.39%
VSTM - ZLDAF
47%
Loosely correlated
+4.58%
QLGN - ZLDAF
28%
Poorly correlated
+2.40%
GNLX - ZLDAF
25%
Poorly correlated
-4.67%
SNSE - ZLDAF
22%
Poorly correlated
+4.14%
KRON - ZLDAF
20%
Poorly correlated
-0.76%
More